共 50 条
- [32] Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 47 - 55
- [33] Metabolic Syndrome in Patients with Type II Diabetes Mellitus [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (01): : 191 - 193
- [35] Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 28L - 33L
- [39] Association of leukocyte telomere length with metabolic syndrome in type 2 diabetes mellitus [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):